| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 09/21/2000 | CA2364739A1 Regulators of intracellular phosphorylation |
| 09/21/2000 | CA2364635A1 47 human secreted proteins |
| 09/21/2000 | CA2361819A1 Amide derivatives |
| 09/20/2000 | EP1036177A1 Novel vectors and genes exhibiting increased expression |
| 09/20/2000 | EP1036095A1 Oxygen-transporting albumin-based blood replacement composition and blood volume expander |
| 09/20/2000 | EP1036072A1 Thrombin receptor antagonists |
| 09/20/2000 | EP1036063A1 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors |
| 09/20/2000 | EP1036061A1 New compounds |
| 09/20/2000 | EP1035868A1 Use of a fibrinogen receptor-antagonist for preventing disseminated intravascular coagulation |
| 09/20/2000 | EP1035824A1 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
| 09/20/2000 | EP0742834B1 Method of preparing a viral vector of at least 20kb by intermolecular recombination in a procaryotic cell |
| 09/20/2000 | EP0734376B1 Vitamin d amine and amide derivatives |
| 09/20/2000 | CN1267306A Cyclopeptide derivs. as adhesion inhibitors |
| 09/20/2000 | CN1267296A Barbituric acid derivs with antimetastatic and antitumor activity |
| 09/20/2000 | CN1056609C Benzoyl guanidines, their production and their use in medicinal compositions |
| 09/20/2000 | CN1056608C Pseudodipeptide product having imidazole group and applications |
| 09/20/2000 | CN1056514C Quick blood-forming agent |
| 09/19/2000 | US6121435 Nematode-extracted serine protease inhibitors and anticoagulant proteins |
| 09/19/2000 | US6121308 Indole and benzimidazole antithrombotic compounds, such as 1-methyl-2-(n-(4-amidinophenyl)-aminomethyl)-5-(n-(hydroxycarbonylmethyl) -quinoline-8-sulphonylamino)-indole |
| 09/19/2000 | US6121253 Prostaglandin conjugates for treating or preventing bone disease |
| 09/19/2000 | US6121238 Peptides and compounds that bind to a receptor |
| 09/19/2000 | US6121018 Polynucleotide which codes for polypeptide of defined amino acid sequence; for therapy and diagnosis of alzheimer's/ parkinson's diseases, multiple sclerosis, amyotrophic lateral sclerosis, septic shock, osteoporosis and other diseases |
| 09/19/2000 | US6120761 Mixture containing histidine stabilizer |
| 09/19/2000 | US6119503 Universal die holder assembly for press brakes |
| 09/17/2000 | CA2300782A1 Modified factor viii cdna |
| 09/14/2000 | WO2000053742A2 Polynucleotides and proteins encoded thereby |
| 09/14/2000 | WO2000053733A2 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof |
| 09/14/2000 | WO2000053637A1 INCLUSION COMPLEXES OF POLYUNSATURATED FATTY ACIDS AND THEIR DERIVATIVES WITH η-CYCLODEXTRIN |
| 09/14/2000 | WO2000053634A1 Single-stranded fv inducing apoptosis |
| 09/14/2000 | WO2000053606A1 Pyridoxal analogues for vitamin b-6 disorders |
| 09/14/2000 | WO2000053604A1 Carbamoyl tetrahydropyridine derivatives |
| 09/14/2000 | WO2000053264A1 Treatment of thrombosis by combined use of a factor xa inhibitor and aspirin, tissue plasminogen activator (tpa), a gpiib/iiia antagonist, low molecular weight heparin or heparin |
| 09/14/2000 | WO2000053233A1 Use of protein conformation for the protection and release of chemical compounds |
| 09/14/2000 | WO2000053168A2 Synergy between low molecular weight heparin and platelet aggregation inhibitors, for preventing and treating thromboembolic disorders |
| 09/14/2000 | WO2000031263A3 Gtpase associated proteins |
| 09/14/2000 | WO2000030668A8 Use of parvovirus capsid particles in the inhibition of cell proliferation and migration |
| 09/14/2000 | WO2000026395A3 Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors |
| 09/14/2000 | WO2000024893A3 Methods and compositions for the prevention and treatment of anemia |
| 09/14/2000 | WO2000024770A3 Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity |
| 09/14/2000 | WO2000023588B1 G-protein coupled receptors |
| 09/14/2000 | CA2366719A1 Solubilization of polyunsaturated fatty acids and their derivatives by formation of inclusion complexes with y-cyclodextrin and their use in pharmaceutical, cosmetic or food compositions |
| 09/14/2000 | CA2366642A1 Carbamoyl tetrahydropyridine derivatives |
| 09/14/2000 | CA2366602A1 Pyridoxal analogues for vitamin b-6 disorders |
| 09/14/2000 | CA2366124A1 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof |
| 09/14/2000 | CA2364252A1 Synergy between low molecular weight heparin and platelet aggregation inhibitors, providing a combination therapy for the prevention and treatment of various thromboembolic disorders |
| 09/14/2000 | CA2362422A1 Polynucleotides and proteins encoded thereby |
| 09/14/2000 | CA2361650A1 Treatment of thrombosis by combined use of a factor xa inhibitor and aspirin, tissue plasminogen activator (tpa), a gpiib/iiia antagonist, low molecular weight heparin or heparin |
| 09/13/2000 | EP1034189A1 Heparin-like compounds, their preparation and use to prevent arterial thrombosis associated with vascular injury and interventions |
| 09/13/2000 | EP1034001A1 Cd154 blockade therapy for therapeutic protein inhibitor syndrome |
| 09/13/2000 | EP1033984A1 Concentrate for medical solution and use thereof |
| 09/13/2000 | EP1033910A1 Dipeptide apoptosis inhibitors and the use thereof |
| 09/13/2000 | CN1266429A Novel pentaerythrite derivatives, the production and use thereof and intermediate products for the synthesis of the same |
| 09/13/2000 | CN1266427A New amidino derivatives and their use as thrombin inhibitors |
| 09/13/2000 | CN1266100A Chemical synthesis, expression and recombinant protein production for human serum albumin reformed gene |
| 09/13/2000 | CN1266097A Process for preparing recombinant natookinase |
| 09/13/2000 | CN1266054A Aryl carboxylic acid and tetrazole derivant |
| 09/13/2000 | CN1265921A Erythropoiesis for treating anemia of family and raised animals |
| 09/13/2000 | CN1056296C Capsule for treating apoplexy |
| 09/13/2000 | CN1056283C Traditional Chinese medicine for treating aftereffect resulted from cerebral embolism |
| 09/12/2000 | US6117910 Bicyclic fibrinogen antagonists |
| 09/12/2000 | US6117888 Thrombin inhibitors |
| 09/12/2000 | US6117866 For inhibiting platelet aggregation or clot formation and reocclusion of an artery or vein in a mammal following fibrinolytic therapy or angioplasty; for treating stroke, transient ischemia attacks, or myocardial infarction |
| 09/12/2000 | US6117836 Glycosylation-mediated inhibition of factor X |
| 09/12/2000 | CA1341097C Factor viii binding domain of von willebrand factor |
| 09/08/2000 | WO2000052145A2 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
| 09/08/2000 | WO2000052057A1 Crystals and structural coordinate of protein complex and utilisation of the structural coordinate |
| 09/08/2000 | WO2000052051A1 Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 09/08/2000 | WO2000052028A1 TUMOR NECROSIS FACTOR RECEPTORS 6α and 6$g(b) |
| 09/08/2000 | WO2000051989A1 Pyrazole-3-on-derivative as factor xa inhibitors |
| 09/08/2000 | WO2000051988A1 Nitroxyderivatives having antiinflammatory, analgesic and antithrombotic activity |
| 09/08/2000 | WO2000037472A3 Substituted pirroloindoles |
| 09/08/2000 | WO2000029583A3 Immunoglobulin superfamily proteins |
| 09/08/2000 | WO2000027414A3 Inhibition of the formation of vascular hyperpermeability |
| 09/08/2000 | WO2000013702A3 Use of an angiogenic factor for the treatment of microvascular angiopathies |
| 09/08/2000 | WO2000012720A3 Elongase genes and uses thereof |
| 09/08/2000 | WO2000012497B1 Quinazoline derivatives as medicaments |
| 09/08/2000 | WO2000007579A3 Use of cyclopentabenzofuran-derivatives for combating nf-$g(k)b-dependent diseases |
| 09/08/2000 | CA2364908A1 Pyrazol-3-one derivatives |
| 09/08/2000 | CA2364415A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
| 09/08/2000 | CA2363961A1 Crystals and structural coordinate of protein complex and utilisation of the structural coordinate |
| 09/08/2000 | CA2361164A1 Nitroxyderivatives having antiinflammatory, analgesic and antithrombotic activity |
| 09/07/2000 | DE19909237A1 Pyrazol-3-on-derivate Pyrazol-3-one derivatives |
| 09/06/2000 | EP1032667A2 A33-related antigens and their pharmacological uses |
| 09/06/2000 | EP1032579A1 Carbohydrate derivatives |
| 09/06/2000 | EP1032575A1 2,3-diaryl-pyrazolo(1,5-b)pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors |
| 09/06/2000 | EP1032560A1 Position-4 substituted 2-pyrrolidinone derivatives to reduce the level of extracellular glutamate |
| 09/06/2000 | EP1032393A1 QUINOLINE-CONTAINING $g(a)-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS |
| 09/06/2000 | EP1032388A1 Novel metal complexes |
| 09/06/2000 | EP1032387A1 Novel metal complexes |
| 09/06/2000 | EP1032370A1 Porous hydroxyapatite particles as carriers for drug substances |
| 09/06/2000 | CN1265647A Acrylic metalloprotease inhibitor |
| 09/06/2000 | CN1265598A Method for treating thrombotic disorders |
| 09/06/2000 | CN1265309A Medicine for rheumatism and aploplexy and its preparation |
| 09/06/2000 | CN1056143C Piperidine derivatives and its use |
| 09/06/2000 | CN1056141C 哌嗪衍生物 Piperazine derivatives |
| 09/06/2000 | CN1056084C Immunotoxins directed against CD33 related surface antigens |
| 09/06/2000 | CN1056049C Preparing process mangetotherapeutic food |
| 09/05/2000 | US6114506 Composition and method for enhancing fibrinolysis |
| 09/05/2000 | US6114367 Such as 3-(3-cyclopentyloxy-4-methoxy)phenyl-2-isoxazoline-5-hydroxamic acid; treating sepsis, septic shock, inflammatory bowel disease, tuberculosis, graft versus host disease or cachexia associated with aids or cancer in a mammal |
| 09/05/2000 | US6114358 Thrombin inhibitors |